EU-OPENSCREEN is intensifying its collaboration with biotech and pharmaceutical companies to support precompetitive, exploratory science, and disruptive technologies that can accelerate chemical biology and early drug discovery.
To support this process, they have created a new brochure “Building innovation in drug discovery” and a dedicated website section “Access for industry”.